Work

Differences in Safety Signal Detection between Osimertinib and First- and Second-Generation EGFR-TKIs: A Pharmacovigilance Study Using a Spontaneous Reporting System

Year: 2025

Type: article

Study design: Observational Study

Source: Oncology

DOI: 10.1159/000548593

Authors: Tomoya Sugimoto, Yoshihiro Noguchi, Rikuto Masuda, Tomohiko Harada, Yukio Toyama, Mitsuru Saguchi, Tomoaki Yoshimura

Institutions: Gifu Pharmaceutical University, Toyota Memorial Hospital

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414507756

FWCI: 2.736

Cites: 22

Cited by: 2

Related to: